Navigation Links
Final Patient Completes Treatment In Boehringer Ingelheim's RE-LY(R) Study, The Largest Atrial Fibrillation Outcomes Trial To Date
Date:3/20/2009

RIDGEFIELD, Conn., March 20 /PRNewswire/ -- Boehringer Ingelheim today announced that the last patient has completed treatment in the Phase III Randomized Evaluation of Long term Anticoagulant therapy (RE-LY(R)) study. This study compared the long-term efficacy and safety of the oral direct thrombin inhibitor dabigatran etexilate with the current standard therapy, warfarin (target international normalized ratio, INR, 2-3) for the prevention of stroke and non-CNS systemic embolism in patients with atrial fibrillation (AF). Dabigatran etexilate is an oral anticoagulant in Phase III development for stroke prevention in AF, as well as several other therapeutic areas. Dabigatran etexilate is not approved by the FDA. RE-LY(R) is the largest AF stroke prevention trial to date. The study enrolled 18,113 patients in more than 900 centers in 44 countries worldwide between December 2005 and December 2007. Data will now be analyzed and results are expected to be presented later this year at the European Society of Cardiology (ESC) Congress, taking place in Barcelona, Spain, from August 29th until September 2nd.

"We are delighted with the completion of treatment in the RE-LY study as it marks an important milestone in the ongoing development of dabigatran etexilate," said Paul Reilly, clinical program director, Boehringer Ingelheim. "We are grateful to the patients and investigators who participated in the study and look forward to further evaluating the safety and efficacy of dabigatran through the analysis of the data."

Atrial fibrillation affects more than 2.2 million Americans, making it the most common heart rhythm disorder in the U.S.(1) People with AF are at increased risk for forming blood clots in their hearts(2) which can raise their risk of stroke five-fold.(3) However, clinical studies show that up to 60 percent of AF related strokes can be prevented with appropriate anticoagulant therapy.(4) Vitamin K antagonists are the c
'/>"/>

SOURCE Boehringer Ingelheim
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Photos: Eight Finalists Lose 685 Pounds and Gain $800,000
2. Clinical Data from Plastic Surgeon in New Jersey Helped in Final Determination of 2008's Top Plastic Surgery Procedures
3. USPTO Issues Notice of Final Determination for Patent Term Extension for NAMENDA(R)
4. Ranbaxy Secures Final FDA Approval for Quinapril Hydrochloride + Hydrochlorothiazide Tablets
5. Nuvos High Throughput Experimentation Platform Selected as 2009 Edison Award Finalist
6. EMPLOYER SURVEY - Final Opportunity to Participate in the UBA Employer Benefits Perspective Survey
7. Final Economic Stimulus Bill Permits Americans Personal Health Information to Be Sold for Research and Public Health Purposes WITHOUT Patients Consent
8. The NBA Teams up With Body By Milk to Challenge Teenagers to Get Fit By Finals
9. OmniPod(R) Insulin Management System Selected as a Finalist for the 2009 Edison Best New Product Awards(TM)
10. Samplify Systems SAM1600 Family of Analog/Digital Converters Named Finalist in EDN Magazines 19th Annual Innovation Awards
11. Final House Vote on SCHIP Delivers Peace of Mind to Americas Families
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/1/2014)... By Steven Reinberg ... -- Stress at work may raise your risk of heart ... industry or have a blue-collar job, U.S. health officials reported ... they added. "Workplace factors that increase risk include job ... smoke -- and noise," explained lead researcher Dr. Sara Luckhaupt, ...
(Date:8/1/2014)... PROVIDENCE, R.I. [Brown University] New research shows that ... member was incarcerated have a 16-percent greater risk of ... have a family member sent to prison. The finding, ... that the nation,s high rate of imprisonment may be ... some families. , "These people were children when this ...
(Date:8/1/2014)... 2014 Today marks the official ... the convergence of three well respected market leaders ... UT; Premier Imaging Financial Services (PIFS) of Columbus, ... NC. Together these organizations serviced, and will continue ... group practices, including Charlotte Radiology (Charlotte, NC) and ...
(Date:8/1/2014)... WA (PRWEB) August 01, 2014 “When ... problem throughout your entire home.“ In a newly released ... or Attic Insulation Needs To Be Replaced ,” Clean ... deteriorated, become damp, or been infested by critters. ... cleaning quote from Clean Crawls - http://www.cleancrawl.com/contact . ...
(Date:8/1/2014)... According to the Get Rid ... by Vkool.com, this is a comprehensive guide that ... cold sores including:,     Swollen ... sore throat and fever ,     Headache and ... are uncomfortable ,     Drooling in small children ...
Breaking Medicine News(10 mins):Health News:Some Jobs Harder on the Heart Than Others, Report Finds 2Health News:Jailed family member increases risks for kids' adult health 2Health News:Jailed family member increases risks for kids' adult health 3Health News:Three Market Leaders Come Together As One To Form A New Breed of Medical Billing Companies 2Health News:Three Market Leaders Come Together As One To Form A New Breed of Medical Billing Companies 3Health News:5 Signs That Insulation Should Be Replaced Detailed in a Newly Released Article By Clean Crawls 2Health News:Get Rid Of Cold Sores Fast Book Review Exposes Ellie Gadsby's Guide For Treating Fever Blisters – Vkool.com 2Health News:Get Rid Of Cold Sores Fast Book Review Exposes Ellie Gadsby's Guide For Treating Fever Blisters – Vkool.com 3
... Harris ... , ... 2009 -- Harris Williams & Co. is pleased to announce that Verathon Inc., a portfolio ... buyer Roper Industries (NYSE: ROP). Harris Williams & Co. acted as the exclusive advisor ...
... , HOLMDEL, ... Sparta Systems, Inc., the maker of TrackWise (®) software ... solutions, is pleased to announce new additions to the TrackWise ... Medical Device Vigilance reporting. The addition of ClinicalTrials.gov reporting ...
... , , , ... Quality Alliance (MTQUA, http://www.mtqua.org ), announces the first ... medical travel providers worldwide. , "All medical tourists who want ... medical travel with a Certified International Patient Advisor (CIPA) and ...
... 2010 AIUM Annual Convention and Preconvention Program, the only ... all disciplines of medical ultrasound, to be held March ... Convention focuses on emerging applications and unique opportunities for ... continues to advance and expand into new arenas. ...
... not being vaccinated against the seasonal flu any more often ... the importance of influenza vaccines resulting from the worldwide outbreak ... study. As of the middle of November, about 32 ... recommended to receive a flu vaccination had been inoculated against ...
... Finding is good news for first-line treatment in Africa, researchers ... finding that has implications for how the AIDS virus is ... be given without routine monitoring by lab tests. , But ... to monitor the progression of the disease and guide the ...
Cached Medicine News:Health News:Harris Williams & Co. Advises Verathon Inc. in its Sale to Strategic Buyer Roper Industries 2Health News:Harris Williams & Co. Advises Verathon Inc. in its Sale to Strategic Buyer Roper Industries 3Health News:TrackWise(R) Electronic Regulatory Reporting Solution Enables Companies to Meet Current and Future Mandates 2Health News:TrackWise(R) Electronic Regulatory Reporting Solution Enables Companies to Meet Current and Future Mandates 3Health News:Medical Travel Quality Alliance to Certify Medical Tourism Agents for Safer, Quality Health Care for Traveling International Patients 2Health News:AIUM gears up for 2010 Annual Convention in San Diego, Calif. 2Health News:American adults receiving flu vaccine at about the same rate as in 2008, study finds 2Health News:American adults receiving flu vaccine at about the same rate as in 2008, study finds 3
(Date:8/1/2014)... Aug. 1, 2014 Research and ... "Global Medical Biosensors Market 2014-2018" report ... http://photos.prnewswire.com/prnh/20130307/600769 Medical biosensors are used ... physicochemical detectors. These biosensors monitor health status, disease ... non-invasive methods. They are cost-effective and user-friendly devices. ...
(Date:8/1/2014)... and PALO ALTO, Calif. , Aug. ... Inc. (CFRI) today announced a partnership to expand awareness ... community through the CFChef Shares program. CFChef Shares will ... part of AbbVie,s CFChef program – an online resource ... to maintain a healthy diet by submitting recipes to ...
(Date:8/1/2014)... DALLAS , August 1, 2014 ... Care Market by Type (Traditional Wound Closure, Anti infective), ... Active (Artificial Skin & Skin Substitutes), Pressure Relief ... by MarketsandMarkets, the global Wound Care Market is expected ... Billion in 2014, growing at a CAGR of ...
Breaking Medicine Technology:Global Medical Biosensors Market 2014-2018: Key Vendors are Abbott, Bayer, LifeScan and F. Hoffmann-La Roche 2AbbVie and Cystic Fibrosis Research, Inc. (CFRI) Team Up to Raise Awareness of the Nutritional Needs of CF Patients through the CFChef Shares Program 2AbbVie and Cystic Fibrosis Research, Inc. (CFRI) Team Up to Raise Awareness of the Nutritional Needs of CF Patients through the CFChef Shares Program 3Wound Care Market Worth $18.3 Billion by 2019 2Wound Care Market Worth $18.3 Billion by 2019 3
For the quantitative determination of Alanine Aminotransferase in serum. Optimized IFCC without P-5'-P, Linearity: 500 IU/L at 37 C. Liquid Working Reagent prepared with simple 1:9 dilution....
Intended for the quantitative determination of total protein in serum. Reaction: endpoint. Wavelength: 540 nm. Linearity: 12 g/dL (120 g/L). Ready to use liquid reagent....
Urea nitrogen (BUN) liquid reagent is used for the kinetic quantitative determination of Urea Nitrogen (BUN) in human serum used in routine examination and monitoring of therapy and relapses....
For the direct colorimetric determination of Urea Nitrogen (BUN) in human serum or plasma....
Medicine Products: